Physician profile
James Tomkinson
NPI 1013413814
$1,995.97
in general payments reported to CMS, 2019-2025
13 companies · $800 in 2025
The $800 reported for 2025 was more than what 79% of Sleep Medicine (Pediatrics) providers received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.87 · 2022: $52.26 · 2023: $456 · 2024: $667 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $629.72 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $393.55 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $253.24 | 2023-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $194.47 | 2023-2025 | |
| Zoll Respicardia, INC. | $164.97 | 2024 | Remede System |
| Avadel Cns Pharmaceuticals, LLC | $124.99 | 2025 | Lumryz |
| Aerin Medical INC. | $51.20 | 2025 | |
| Pfizer INC. | $39.52 | 2022 | |
| Sanofi Pasteur INC. | $35.62 | 2023 | |
| Corium, LLC | $32.74 | 2023 | Azstarys |
| Cranial Technologies, INC | $31.32 | 2022-2023 | Doc Band |
| Itamar Medical INC | $23.76 | 2025 | Watchpatone |
| Merck Sharp & Dohme LLC | $20.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tomkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.